Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients

Ethan Tang, Andrew Rowland, Ross A. McKinnon, Michael J. Sorich, Ashley M. Hopkins

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences